Summary

Market Introduction

The global digital therapeutics market includes clinically validated software and devices that are evidence-based. These tools are intended for the treatment of a wide range of diseases and conditions. Furthermore, digital therapeutics can be used either on their own or in combination with other devices to manage both physical and behavioural health issues.

Impact Analysis:

The digital therapeutics market has made an impact in the following ways:

• Increased Accessibility of Care: Digital therapeutics provide convenient and accessible care, especially for patients in remote areas or those with mobility limitations. By offering expanded access, digital therapeutics are helping to improve health outcomes and reduce disparities in healthcare delivery, making quality care more available to those who need it most.
• Improved Patient Engagement and Adherence: Digital therapeutics enable personalized interventions and offer patients real-time feedback and support, which boosts engagement and adherence to treatment plans. This personalized approach leads to improved health outcomes and helps reduce healthcare costs by preventing complications and minimizing the need for more intensive treatments.
• Enhanced Data Collection and Analysis: Digital therapeutics facilitate continuous data collection on patients' health and behaviour, offering valuable insights for healthcare providers and researchers. These insights help tailor personalized treatment strategies and contribute to the development of new, innovative solutions to address a wider range of health challenges.
• Reduced Costs of Healthcare Delivery: By enabling early intervention and promoting self-management of chronic conditions, digital therapeutics have the potential to reduce reliance on traditional healthcare services. This shift not only empowers patients but also leads to significant cost savings for both patients and healthcare systems.

Market Segmentation:

Segmentation 1: by Product Type
• Software
• Devices

Segmentation 2: by Application
• Treatment/Patient Care-Related Applications
• Preventive Applications

Segmentation 3: by Sales Channel
• Business-to-Business
• Business-to-Customer

Segmentation 4: by Region
• North America - U.S., Canada
• Europe - U.K., Germany, France, Italy, Spain, and Rest-of-Europe
• Asia-Pacific - China, Japan, India, South Korea, Australia, and Rest-of-Asia-Pacific
• Latin America - Brazil, Mexico, and Rest-of-Latin America
• Middle East and Africa - K.S.A., U.A.E., Israel, South Africa, and Rest-of-Middle East and Africa

China led the Asia-Pacific digital therapeutics market in 2024, driven by its large population facing chronic conditions like diabetes, hypertension, and cardiovascular diseases. Digital therapeutics provides effective and accessible solutions for managing these health issues. The Chinese government acknowledges the potential of digital therapeutics and is actively supporting its development and adoption to improve healthcare delivery and outcomes.

Recent Developments in the Digital Therapeutics Market

• In November 2023, Vida Health teamed up with Capital Rx to launch Rx Activate, a comprehensive program focused on managing chronic conditions.
• In November 2023, Vida Health partnered with Withings Health Solutions to improve virtual cardiometabolic care through the integration of advanced health monitoring tools.
• In September 2023, Click Therapeutics, Inc. announced a partnership with Indivior to co-develop and commercialize cutting-edge prescription digital therapeutics for substance use disorders.
• In July 2023, ResMed Inc. finalized the acquisition of Somnoware, a leading provider of digital therapeutics for sleep and respiratory care diagnostics.
• In April 2023, Glooko, Inc. joined forces with Hedia, incorporating Hedia's technology into Glooko’s diabetes management platform. The collaboration aims to provide an interoperable solution that integrates connected care, remote patient monitoring, and digital therapeutics to better serve individuals with Type 1 and Type 2 diabetes needing bolus insulin dosing advice.
• In February 2023, Glooko, Inc. entered into a global collaboration with Sanofi to enhance diabetes care by integrating SoloSmart with the Glooko platform, supporting both patients and healthcare providers.
• In January 2023, Omada Health Inc. partnered with Intermountain Healthcare and Castell to launch an integrated virtual care option aimed at diabetes management and prevention.

Demand – Drivers and Limitations

Market Demand Drivers of digital therapeutics market:

• Multiple Benefits Provided by Digital Therapeutics over Traditional Treatment: The adoption of digital therapeutics is rapidly increasing, driven by their personalized, technology-based approach to managing a wide range of conditions. Unlike traditional treatments, digital therapeutics offer real-time monitoring, data collection, and customized interventions that are tailored to individual patient needs. This shift marks a significant transformation in healthcare, positioning digital therapeutics market as a promising area of growth and ushering in a new era of patient-centred care.

• Continuous Technological Advancements Driving the Adoption of Digital Therapeutics: Digital therapeutics is experiencing rapid growth, fuelled by advances in technology and the widespread use of smartphones. This synergy allows digital therapeutics to create intuitive solutions that are set to transform healthcare and improve patient outcomes. Artificial intelligence within digital therapeutics personalizes and tailors interventions, while big data equips healthcare professionals with valuable insights to enhance care. Mobile health platforms powered by digital therapeutics increase accessibility, and real-time monitoring ensures continuous, ongoing care. The future of digital therapeutics is promising, with the potential to reshape healthcare and significantly improve global health outcomes.

• Increasing Demand for Cost-Effective Solutions Creating a Demand for Digital Therapeutics: As healthcare costs continue to rise, digital therapeutics are emerging as a cost-effective alternative. By harnessing technology for personalized care and continuous monitoring, digital therapeutics help reduce the need for expensive hospitalizations and in-person visits. This leads to significant cost savings while also improving patient outcomes. Digital therapeutics make healthcare more accessible and sustainable, particularly for underserved populations. The potential of digital therapeutics to revolutionize care is immense, positioning them to transform healthcare and drive improvements in global health in the future.

Market Restraints:

• Data Privacy and Security Concerns: Digital therapeutics market have the potential to revolutionize healthcare, but ethical concerns like data privacy, algorithmic bias, and transparency must be addressed. The extensive data collection required by digital therapeutics raises privacy issues, while biased algorithms could compromise fairness. To fully realize their potential, robust regulations on data privacy, fairness, and transparency are essential. This requires collaboration between policymakers, healthcare providers, and tech companies to ensure that digital therapeutics evolve responsibly while prioritizing patient well-being.

• Lack of Standardized Reimbursement Models: The lack of standardized reimbursement models is a major barrier to the widespread adoption of digital therapeutics by both healthcare providers and patients. Without standardized reimbursement for digital therapeutics, these innovative solutions remain out of reach for many who could benefit. To make digital therapeutics accessible to those in need, establishing clear reimbursement standards is crucial. Collaboration among stakeholders is essential to address this challenge, enabling digital therapeutics to reach their full potential and ultimately improve healthcare delivery and patient outcomes.

Market Opportunities:

• Expanding Applications of Digital Therapeutics: The scope of digital therapeutics market is rapidly expanding beyond its original focus, now tackling areas like pain management, addiction, and rehabilitation, among others. This growth is driven by the growing recognition of their effectiveness in addressing a broader array of health challenges. As digital therapeutics market continue to expand into new domains, they are set to revolutionize healthcare delivery, enhance patient outcomes across a wider spectrum of conditions, and empower individuals to take control of their health for an improved quality of life.

• Rising Fundings and Investment in Digital Therapeutics: The digital therapeutics market is witnessing a surge in investment, driving its growth and opening the door to significant healthcare advancements. This influx of capital comes from the growing recognition of digital therapeutics' market potential to transform disease management, improve patient outcomes, and boost healthcare efficiency. As investments keep flowing, digital therapeutics are set to revolutionize disease management, enhance patient outcomes, and streamline healthcare delivery, ultimately shaping the future of healthcare worldwide.

How can this report add value to an organization?

Product/Innovation Strategy: The global digital therapeutics market is extensively segmented across various categories, such as product type, application, sales channel, and region. Each region undergoes a detailed analysis based on digital therapeutics product type, application, and sales channel. This segmentation offers readers a clear overview of which digital therapeutics segments currently dominate the market, and which ones are well-positioned for growth in the future.

Growth/Marketing Strategy: Synergistic activities represented the largest share of key developments, with approximately 64.44% of all developments in the global digital therapeutics market occurring between January 2020 and November 2023.

Competitive Strategy: The global digital therapeutics market is home to numerous established players, each offering product portfolios that address a wide array of conditions. Key players analysed and profiled in the study include prominent companies providing diverse digital therapeutics solutions for treatment, patient care, and preventive applications.

Methodology

Key Considerations and Assumptions in Digital therapeutics market Engineering and Validation

• Detailed secondary research was performed to ensure maximum coverage of manufacturers/suppliers operational in a country.
• Exact revenue information, up to a certain extent, was extracted for each company from secondary sources and databases. The revenues specific to the product type/application/sales channel were then estimated for each market player based on fact-based proxy indicators as well as primary inputs.
• The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of digital therapeutics.
• The market contribution of the digital therapeutics anticipated to be launched in the future has been calculated based on historical analysis. This analysis has been supported by proxy factors such as the innovation scale of the companies, the status of funding, collaborations, customer base, and patent scenario.
• The scope of availability of digital therapeutics in a particular region has been assessed based on a comprehensive analysis of companies’ prospects, regional end-user perception, and other factors impacting the launch of digital therapeutics in that region.
• Revenues of the companies have been referenced from their annual reports for FY2020-FY2022. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, product approval status, market collaborations, and operational history.
• Regional distribution of the market revenue has been estimated based on the companies in each region and the adoption rate of digital therapeutics. All the numbers have been adjusted to a single digit after the decimal for better presentation in the report. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. The CAGR has been calculated for the period 2025-2035.
• The market has been mapped based on the available digital therapeutics. All the key companies with significant offerings in this field have been considered and profiled in this report.
• Market strategies and developments of key players have been considered for the calculation of the potential of the market in the forecast period.

Primary Research:

The primary sources involve industry experts in the digital therapeutics market, including the market players offering digital therapeutics solutions. Resources such as CXOs, vice presidents, product managers, directors, territory managers, and business development have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

• Validation and triangulation of all the numbers and graphs
• Validation of the report’s segmentation and key qualitative findings for digital therapeutics
• Understanding the competitive landscape and business model
• Current and proposed production values of a product by market players
• Validation of the numbers of the different segments of the market in focus
• Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

• Digital Therapeutics Alliance (DTA), Frontiers, World Health Organization (WHO), and National Center for Biotechnology Information (NCBI), among others
• Annual reports, SEC filings, and investor presentations of the leading market players
• Company websites and detailed study of their portfolios
• Gold standard magazines, journals, whitepapers, press releases, and news articles
• Databases

The key data points taken from the secondary sources include:

• Segmentation and percentage share estimates
• Company and country understanding, and data for market value estimation
• Key industry/market trends
• Developments among top players
• Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies featured have been selected based on insights gathered from primary experts, as well as an analysis of their company coverage, product portfolio, and market penetration.

Some prominent names in the global digital therapeutics market include:

• Akili Interactive Labs, Inc.
• Lark Technologies, Inc.
• 2Morrow Inc.
• Click Therapeutics, Inc.
• Biofourmis Inc.
• Glooko, Inc.
• CureApp, Inc.
• Cognoa, inc.
• Omada Health Inc.
• Cara Care
• Neurotrack Technologies, Inc.
• Kaia Health, inc.
• ResMed Inc.
• Vida Health
• Vivante Health, Inc.

ページTOPに戻る

Table of Contents

Executive Summary
Scope of the Study
1. Global Digital Therapeutics Market Overview
1.1 Trends: Current and Future Impact Assessment
1.1.1 Trend 1: Expansion across Therapeutic Area
1.1.2 Trend 2: Integration with the Healthcare Ecosystem
1.1.3 Trend 3: Utilization of Artificial Intelligence (AI) and Machine Learning (ML) with Digital Therapeutics
1.2 Value Chain Analysis
1.3 Funding Activities
1.4 Regulatory Framework
1.5 Patent Analysis
2. Market Dynamics
2.1.1 Impact Analysis
2.1.2 Market Drivers
2.1.3 Market Restraints
2.1.4 Market Opportunities
3. Global Digital Therapeutics Market Analysis (By Product Type), $Million, 2024-2035
3.1 Overview
3.2 Growth-Share Matrix
3.3 Product Type
3.4 Software
3.5 Devices
4. Global Digital Therapeutics Market Analysis (By Application), $ Million, 2024-2035
4.1 Overview
4.2 Growth-Share Matrix
4.3 Application Summary
4.4 Treatment/Patient Care-Related Applications
4.4.1 Diabetes
4.4.2 Neurological Disorders
4.4.3 Smoking Cessation
4.4.4 Chronic Respiratory Disorders
4.4.5 Gastrointestinal Disorders
4.4.6 Cardiovascular Disorders
4.4.7 Medication Adherence
4.4.8 Rehabilitation and Patient Care
4.4.9 Others
4.5 Preventive Applications
4.5.1 Nutrition Management
4.5.2 Lifestyle Management
4.5.3 Others
5. Global Digital Therapeutics Market Analysis (By Sales Channel), $Million, 2024-2035
5.1 Overview
5.2 Sales Channel Summary
5.3 Business-to-Business
5.3.1 Insurance Providers/Corporate Employer
5.3.2 Pharmaceutical Companies
5.3.3 Others
5.4 Business-to-Customer
5.4.1 Patients
5.4.2 Caregivers
6. Global Digital Therapeutics Market Analysis (By Region), $ Million, 2024-2035
6.1 Regional Summary
6.2 North America
6.2.1 Regional Overview
6.2.2 Driving Factors for Market Growth
6.2.3 Factors Challenging the Market Growth
6.2.4 U.S.
6.2.5 Canada
6.3 Europe
6.3.1 Regional Overview
6.3.2 Driving Factors for Market Growth
6.3.3 Factors Challenging the Market Growth
6.3.4 U.K.
6.3.5 Germany
6.3.6 France
6.3.7 Italy
6.3.8 Spain
6.3.9 Rest-of-Europe
6.4 Asia-Pacific
6.4.1 Regional Overview
6.4.2 Driving Factors for Market Growth
6.4.3 Factors Challenging the Market Growth
6.4.4 China
6.4.5 Japan
6.4.6 India
6.4.7 Australia
6.4.8 South Korea
6.4.9 Rest-of-Asia-Pacific
6.5 Latin America
6.5.1 Regional Overview
6.5.2 Driving Factors for Market Growth
6.5.3 Factors Challenging the Market Growth
6.5.4 Brazil
6.5.5 Mexico
6.5.6 Rest-of-Latin America
6.6 Middle East and Africa
6.6.1 Regional Overview
6.6.2 Driving Factors for Market Growth
6.6.3 Factors Challenging the Market Growth
6.6.4 KSA
6.6.5 U.A.E.
6.6.6 Israel
6.6.7 South Africa
6.6.8 Rest-of-Middle East and Africa
7. Global Digital Therapeutics Market - Competitive Benchmarking and Company Profiles
7.1 Next Frontiers
7.2 Competitive Analysis
7.3 Global Ecosystem Glimpse
7.4 Geographic Assessment
7.4.1 Akili Interactive Labs, Inc.
7.4.1.1 Company Overview
7.4.1.2 Product Portfolio
7.4.1.3 Key Competitors
7.4.1.4 Target Customers
7.4.1.5 Analyst Perspective
7.4.2 Lark Technologies Inc.
7.4.2.1 Company Overview
7.4.2.2 Product Portfolio
7.4.2.3 Key Competitors
7.4.2.4 Target Customers
7.4.2.5 Analyst Perspective
7.4.3 2Morrow Inc.
7.4.3.1 Company Overview
7.4.3.2 Product Portfolio
7.4.3.3 Key Competitors
7.4.3.4 Target Customers
7.4.3.5 Analyst Perspective
7.4.4 CureApp, Inc.
7.4.4.1 Company Overview
7.4.4.2 Product Portfolio
7.4.4.3 Key Competitors
7.4.4.4 Target Customers
7.4.4.5 Analyst Perspective
7.4.5 Cognoa, Inc.
7.4.5.1 Company Overview
7.4.5.2 Product Portfolio
7.4.5.3 Key Competitors
7.4.5.4 Target Customers
7.4.5.5 Analyst Perspective
7.4.6 Omada Health, Inc.
7.4.6.1 Company Overview
7.4.6.2 Product Portfolio
7.4.6.3 Key Competitors
7.4.6.4 Target Customers
7.4.6.5 Analyst Perspective
7.4.7 Care Care
7.4.7.1 Company Overview
7.4.7.2 Product Portfolio
7.4.7.3 Key Competitors
7.4.7.4 Target Customers
7.4.7.5 Analyst Perspective
7.4.8 Biofourmis, Inc.
7.4.8.1 Company Overview
7.4.8.2 Product Portfolio
7.4.8.3 Key Competitors
7.4.8.4 Target Customers
7.4.8.5 Analyst Perspective
7.4.9 Glooko, Inc.
7.4.9.1 Company Overview
7.4.9.2 Product Portfolio
7.4.9.3 Key Competitors
7.4.9.4 Target Customers
7.4.9.5 Analyst Perspective
7.4.10 Neurotrack Technologies, Inc.
7.4.10.1 Company Overview
7.4.10.2 Product Portfolio
7.4.10.3 Key Competitors
7.4.10.4 Target Customers
7.4.10.5 Analyst Perspective
7.4.11 Kaia Health
7.4.11.1 Company Overview
7.4.11.2 Product Portfolio
7.4.11.3 Key Competitors
7.4.11.4 Target Customers
7.4.11.5 Analyst Perspective
7.4.12 ResMed, Inc.
7.4.12.1 Company Overview
7.4.12.2 Product Portfolio
7.4.12.3 Key Competitors
7.4.12.4 Target Customers
7.4.12.5 Analyst Perspective
7.4.13 Vivante Health
7.4.13.1 Company Overview
7.4.13.2 Product Portfolio
7.4.13.3 Key Competitors
7.4.13.4 Target Customers
7.4.13.5 Analyst Perspective
8. Research Methodology

Press Release